BioLine RX Ltd Cash Flow Quality Index
BioLine RX Ltd cash flow quality index. BioLine RX Ltd (BLRX) has a Cash Flow Quality Index of -0.51x as of March 2025. Operating cash flow of ILA-2.59 Million is below net income of ILA5.13 Million, suggesting accrual-heavy earnings not yet converted to cash. See how financially flexible is BioLine RX Ltd to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of BioLine RX Ltd (2010–2010)
Cash flow quality index of BioLine RX Ltd from 2010 to 2010. Historical Cash Flow Quality Index for BioLine RX Ltd across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore BLRX operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
BioLine RX Ltd Cash Flow Quality Index by Year (2010–2010)
BioLine RX Ltd cash flow quality index by year from 2010 to 2010. Year-by-year earnings quality comparison for BioLine RX Ltd. For the full cash flow conversion analysis, see BLRX cash generation efficiency.
| Year | Quality Index | Operating CF (ILA) | Net Income | YoY Change |
|---|---|---|---|---|
| 2010 | 5.47x | ILA11.46 Million | ILA2.10 Million | — |